CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CBDL · as of Jun 8, 2026
Key Statistics
Explore CBD Life Sciences Inc. Data
cbdl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
cbdl competitorsCBDL
AOXG
ETBI
GPFT
HPMM
IVIXFStock Performance
Full HistoryAbout CBD Life Sciences Inc.
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topi…
what is cbd life sciences inc. · cbdl stock overview · cbd life sciences inc. company profile · who is cbd life sciences inc. ceo · cbdl OTC · cbd life sciences inc. headquarters · cbd life sciences inc. business segments
About Stock Overview & Key Data
CBD Life Sciences Inc. (CBDL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Sep 11, 2009. As of the latest trading session, CBDL stock price is $0.00, with a market capitalization of $469,243. The stock has returned -16.67% over the past 12 months and +25.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for CBD Life Sciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, CBD Life Sciences Inc. reported revenue of $98321.00 and net income of -$48929.00. For detailed data — including CBD Life Sciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CBD Life Sciences Inc. (CBDL) stock price is $0.00. The stock is traded on OTC under the ticker symbol CBDL. The 52-week range is $0.00 – $0.00.